CastiaRx was rebranded in April 2018 as the PBM division within Diplomat Pharmacy, the largest independent provider of specialty pharmacy services in the U.S. Prior to the rebrand, the legacy PBM had roots dating back 50 years and now offers healthcare payers a pharmacy management solution grounded in the treatment of specialty conditions. CastiaRx is led by a seasoned team of pharmacists and PBM veterans who possess a keen understanding of today’s pharmacy benefit challenges. They understand what drives pharmacy trend and, more importantly, solve the payers needs of today as well as anticipating future priorities in this fast-changing industry. “We can administer your current pharmacy benefits, or analyze and model the impact of plan changes you may want to consider for mail order, clinical programs, or with your formulary,” states Luthin.
![]()
We bring a broader depth of services and expertise to address the intricacies of specialty pharmacy management under both the pharmacy and medical benefit
By staying on top of pharmacy trends, industry shifts, and the new drug pipeline, CastiaRx guides its clients to manage costs and avoid surprises. The company’s advanced data warehouse offers extensive drill-down capabilities to examine pharmacy trends from multiple perspectives and helps benchmark results against industry peers. “Through quarterly reports and annual plan reviews, we deliver plan and program results as well as an actionable set of insights you can use to tune plan performance,” says Luthin. CastiaRx also provides intuitive digital tools, which include a mobile app and a web portal to help patients manage their medications.
As more and more specialty drugs come to market, it is easy for healthcare payers to be overwhelmed. CastiaRx is well-positioned to help clients manage their drug spend and make the patient journey easier. CastiaRx brings together two critical elements, a foundation in specialty and PBM expertise, to simplify the complexity inherent in specialty drug management and help payers address this growing challenge.